Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Ageing Research Reviews

• Publication date

  2004-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.ARR.2004.01.002PMID 15231239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

  2003cited by this paper
• Copper, zinc, and the metallobiology of Alzheimer disease.

  2003cited by this paper
• Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.

  2003cited by this paper
• Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease

  2003cited by this paper
• Metals and oxidative homeostasis in Alzheimer's disease

  2002cited by this paper
• The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease

  2002cited by this paper
• 8 – Prion and Alzheimer Diseases: The Road to Pathogenesis is Paved with Copper

  2002cited by this paper
• High Molecular Weight Neurofilament Proteins Are Physiological Substrates of Adduction by the Lipid Peroxidation Product Hydroxynonenal*

  2002cited by this paper
• Elevation of serum copper levels in Alzheimer’s disease

  2002cited by this paper
• The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders

  2002cited by this paper
• Mitochondrial Abnormalities in Alzheimer's Disease

  2001cited by this paper
• Copernicus revisited: amyloid beta in Alzheimer's disease.

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper
• Axonal Tau mRNA Localization Coincides with Tau Protein in Living Neuronal Cells and Depends on Axonal Targeting Signal

  2001cited by this paper
• Redox-active iron mediates amyloid-β toxicity

  2001cited by this paper
• Life span and synapses: will there be a primary senile dementia?

  2001cited by this paper
• Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits*

  2001cited by this paper
• Redox-active iron mediates amyloid-beta toxicity.

  2001cited by this paper
• Neuronal Oxidative Stress Precedes Amyloid‐β Deposition in Down Syndrome

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc*

  2000cited by this paper
• Cell death or synaptic loss in Alzheimer disease.

  2000cited by this paper
• Arson: Tracking the Culprit in Alzheimer's Disease

  2000cited by this paper
• Amyloid-β junkies

  2000cited by this paper
• Amyloid-beta junkies.

  2000cited by this paper
• Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc.

  2000cited by this paper
• Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.

  2000cited by this paper
• Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion*

  1999cited by this paper
• Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?

  1999cited by this paper
• RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease

  1999cited by this paper
• In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.

  1999cited by this paper
• Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease

  1998cited by this paper
• Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide.

  1998cited by this paper
• Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease

  1997cited by this paper
• Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems.

  1997cited by this paper
• 4‐Hydroxynonenal‐Derived Advanced Lipid Peroxidation End Products Are Increased in Alzheimer's Disease

  1997cited by this paper
• Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain.

  1997cited by this paper
• The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis.

  1996cited by this paper
• Oxidative damage in Alzheimer's

  1996cited by this paper
• Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders.

  1996cited by this paper
• In Alzheimer's disease the Golgi apparatus of a population of neurons without neurofibrillary tangles is fragmented and atrophic.

  1996cited by this paper
• Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease

  1996cited by this paper
• Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides

  1996cited by this paper
• Evidence of neuronal oxidative damage in Alzheimer's disease.

  1996cited by this paper
• Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain

  1995cited by this paper
• Early AGEing and Alzheimer's

  1995cited by this paper
• Induction of Heme Oxygenase‐1 mRNA and Protein in Neocortex and Cerebral Vessels in Alzheimer's Disease

  1995cited by this paper
• A tombstone in Alzheimer's?

  1995cited by this paper
• Advanced Maillard reaction end products are associated with Alzheimer disease pathology

  1994cited by this paper
• Analysis of microtubule-associated protein tau glycation in paired helical filaments.

  1994cited by this paper
• Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry.

  1994cited by this paper
• Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

  1994cited by this paper
• Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

  1994cited by this paper
• Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite.

  1989cited by this paper
• Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia

  1967cited by this paper
• Methods of Enzymology.

  1956cited by this paper

• Selective Reversal of Cu-Amyloid Aggregation Monitored in Real Time by Fluorescence Anisotropy: Ni-Bme-Dach vs EDTA Benchmarks.

  2026cites this paper
• Integrated Multi‐Omics Analysis and Cross‐Model Validation Reveal Mitochondrial Signatures in Alzheimer's Disease

  2025cites this paper
• Lead Induced Intracellular Copper Redox Imbalance with Aggravated Cellular Dysfunction.

  2025cites this paper
• The influence of ammonia-N and salinity levels on oxidative stress markers, hepatic enzymes, and acid phosphatase activity in Nile tilapia (Oreochromis niloticus)

  2025cites this paper
• Reversal of atherosclerosis by restoration of vascular copper homeostasis

  2024cites this paper
• Multiplatform lipid analysis of the brain of aging mice by mass spectrometry

  2024cites this paper
• The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

  2023cites this paper
• Phenolic furanochromene hydrazone derivatives: Synthesis, antioxidant activity, ferroptosis inhibition, DNA cleavage and DNA molecular docking studies.

  2022cites this paper
• Application of Phenolic Extraction Strategies and Evaluation of the Antioxidant Activity of Peanut Skins as an Agricultural By-product for Food Industry

  2021cites this paper
• Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders

  2021cites this paper
• Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42)

  2020cites this paper
• Increased oxidative stress, hyperphosphorylation of tau, and dystrophic microglia in the hippocampus of aged Tupaia belangeri

  2020cites this paper
• Noradrenaline Acting on Alpha1 Adrenoceptor as well as by Chelating Iron Reduces Oxidative Burden on the Brain: Implications With Rapid Eye Movement Sleep

  2019cites this paper
• Loss of ferritin‐positive microglia relates to increased iron, RNA oxidation, and dystrophic microglia in the brains of aged male marmosets

  2019cites this paper
• Quinone-Based Antitumor Agent Sepantronium Bromide (YM155) Causes Oxygen-Independent Redox-Activated Oxidative DNA Damage.

  2018cites this paper
• Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs

  2018cites this paper
• Dementia Research: Populations, Progress, Problems, and Predictions

  2018cites this paper
• Altered Potassium Ion Channel Function as a Possible Mechanism of Increased Blood Pressure in Rats Fed Thermally Oxidized Palm Oil Diets

  2018cites this paper
• MALONDIALDEHYDE – OXIDATIVE STRESS MARKER

  2018cites this paper
• Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?

  2018cites this paper
• Effect of Heat Treatment on the Antioxidant Capacity of Aqueous and Ethanol Extracts of Aframomum angustifolium Seed

  2017cites this paper
• Protease activity of legumain is inhibited by an increase of cystatin E/M in the DJ-1-knockout mouse spleen, cerebrum and heart

  2017cites this paper
• Dietary intake omega-3 rich fish oil and management of diabetes

  2017cites this paper
• A REVIEW ARTICLE ON THE FORMATION, MECHANISM AND BIOCHEMISTRY OF MDA AND MDA AS A BIOMARKER OF OXIDATIVE STRESS.

  2017cites this paper
• Structure and function of legumain in health and disease.

  2016cites this paper
• Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer's disease

  2016influential citation
• The aggregation and reduction of iron minerals by the Alzheimer's disease peptide ß-amyloid (1-42) : an X-ray absorption study

  2015cites this paper
• Computer-assisted designed "selenoxy-chinolin": a new catalytic mechanism of the GPx-like cycle and inhibition of metal-free and metal-associated Aβ aggregation.

  2015cites this paper
• Iron, aging, and neurodegeneration

  2015cites this paper
• Oxidative Stress Gated by Fenton and Haber Weiss Reactions and Its Association With Alzheimer’s Disease

  2014cites this paper
• Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

  2014cites this paper
• Capturing a Reactive State of Amyloid Aggregates

  2014cites this paper
• β-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin

  2014cites this paper
• Drug-like chelating agents: a potential lead for Alzheimer's disease

  2014cites this paper
• Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles.

  2014cites this paper
• The effects of different antioxidants on the activity of cerebrocortical MnSOD and Na,K-ATPase from post mortem Alzheimer's disease and age-matched normal brains.

  2014cites this paper
• Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

  2014cites this paper
• Anatomical Region Differences and Age-Related Changes in Copper, Zinc, and Manganese Levels in the Human Brain

  2014cites this paper
• Oxidative Stress in Alzheimer's Disease and Mild Cognitive Impairment with High Sensitivity and Specificity

  2013cites this paper
• Metallobiology of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.

  2013cites this paper
• Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.

  2013cites this paper
• Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease*

  2013cites this paper
• Green Tea Flavan-3-ols and Their Role in Protecting against Alzheimer’s and Parkinson’s Disease Pathophysiology

  2012cites this paper
• An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation.

  2012cites this paper
• Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

  2012cites this paper
• Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

  2012cites this paper
• Mass Spectrometry in the Analysis of DNA, Protein, Peptide, and Lipid Biomarkers of Oxidative Stress

  2011cites this paper
• Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim

  2011cites this paper
• Implicación de los metales y elementos traza en la enfermedad de alzheimer y su asociación con los agentes del estrés oxidativo sistémico

  2011cites this paper
• Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia

  2011cites this paper
• Animal Models of Metallic Dementia

  2011cites this paper
• Oxidative Stress and Alzheimer Disease: Mechanisms and Therapeutic Opportunities

  2011cites this paper
• Mitochondria-targeted amyloid: Relevance to neurotoxicity and Alzheimer's disease

  2011cites this paper
• Oxidative Stress in Alzheimer’s Disease: A Critical Appraisal of the Causes and the Consequences

  2011cites this paper
• Alzheimer disease.

  2010cites this paper
• Roles of dioxins and heavy metals in cancer and neurological diseases using ROS-mediated mechanisms.

  2010cites this paper
• Synthesis and Characterization of Second- Generation Iron Pro-chelators

  2010cites this paper
• Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

  2010cites this paper
• Minding metals: tailoring multifunctional chelating agents for neurodegenerative disease.

  2010cites this paper
• Oxidative Modification of Proteins: An Overview

  2010cites this paper
• Plasma and Cerebro Spinal Fluid Amyloid Beta 42, 40 and the 42:40 ratio for diagnosis of incipient Dementia in a population with objective cognitive decline.

  2010cites this paper
• A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β Aggregation

  2009cites this paper
• Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease

  2009cites this paper
• Neurotrophic Support and Oxidative Stress: Converging Effects in the Normal and Diseased Nervous System

  2009cites this paper
• Oxidative Stress and Autophagy in the Regulation of Lysosome-Dependent Neuron Death

  2009cites this paper
• Geniposide inhibits CoCl2-induced PC12 cells death via the mitochondrial pathway.

  2009cites this paper
• Impact of Magnetic Labeling on Human and Mouse Stem Cells and Their Long-Term Magnetic Resonance Tracking in a Rat Model of Parkinson Disease

  2009cites this paper
• Phosphorylated Tau: Toxic, Protective, or None of the Above

  2008cites this paper
• Cell Signaling Pathways and Iron Chelation in the Neurorestorative Activity of Green Tea Polyphenols: Special Reference to Epigallocatechin Gallate (EGCG)

  2008cites this paper
• 17β‐Oestradiol Stimulation of G‐Proteins in Aged and Alzheimer’s Human Brain: Comparison with Phytoestrogens

  2008cites this paper
• Pharmacological and Clinical Aspects of Heme Oxygenase

  2008cites this paper
• Metal Concentrations in Plasma and Cerebrospinal Fluid in Patients with Alzheimer’s Disease

  2008cites this paper
• Oxidative stress and neurotoxicity.

  2008cites this paper
• Simultaneous Manipulation of Multiple Brain Targets by Green Tea Catechins: A Potential Neuroprotective Strategy for Alzheimer and Parkinson Diseases

  2008cites this paper
• Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches.

  2008cites this paper
• Redox active iron accumulation in aceruloplasminemia

  2008cites this paper
• Physiological and pathological aspects of Aβ in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators

  2008cites this paper
• Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway.

  2007cites this paper
• Brain iron metabolism: neurobiology and neurochemistry.

  2007cites this paper
• Selective oxidation of Zn2+ -insulin catalyzed by Cu2+.

  2007cites this paper
• Selective Oxidation of Zn 2þ —Insulin Catalyzed by Cu 2þ

  2007cites this paper
• Mitochondrial dysfunction in human pathologies.

  2007cites this paper
• Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents.

  2007cites this paper
• Age-dependent oxidation and aggregation of ZnT-1: a role for metal catalyzed oxidation?

  2007cites this paper
• The Role of Oxidative Damage to Nucleic Acids in the Pathogenesis of Neurological Disease

  2007cites this paper
• Nanoparticles: a step forward for iron chelation in the brain

  2007cites this paper
• Building the power house: recent advances in mitochondrial studies through proteomics and systems biology.

  2007cites this paper
• Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis.

  2007cites this paper
• Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).

  2006cites this paper
• Effect of Cu2+ on K+ Current in Acutely Isolated Rat Hippocampal Neurons by Whole Cell Patch Clamp Technique

  2006cites this paper
• Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.

  2006cites this paper
• Molecular and biochemical features in Alzheimer's disease.

  2006cites this paper
• Role of metals in neuronal apoptosis: challenges associated with neurodegeneration.

  2006cites this paper
• Oxidative stress in Alzheimer's disease.

  2006cites this paper
• Characterization of Fe, Cu and Zn in organs of PDAPP transgenic mice by XRF spectrometry †

  2006cites this paper
• Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

  2006cites this paper
• Genetic basis of Alzheimer's dementia: role of mtDNA mutations

  2006cites this paper
• Insulin-like growth factor-1 prevents Aβ[25–35]/(H2O2)- induced apoptosis in lymphocytes by reciprocal NF-κB activation and p53 inhibition via PI3K-dependent pathway

  2006cites this paper
• Mechanisms of DNA Damage and Repair in Alzheimer Disease

  2006cites this paper
• Metal ions and oxidative protein modification in neurological disease.

  2005cites this paper